Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, September 18, 2025.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Countertrend Up (+85) - NBIX is showing short-term weakness. However, look for the longer-term bullish trend to resume. As always, continue to monitor the trend score and utilize a stop order.
Is it time to buy, sell, or avoid NBIX?
MarketClub looks at technical strength and momentum to determine if the timing is right for NBIX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for NBIX
The long-term trend has been UP since Jul 3rd, 2025 at 130.460
The intermediate-term trend has been UP since Aug 26th, 2025 at 137.025
The short-term trend has been DOWN since Sep 15th, 2025 at 140.560
Smart Scan Analysis for NBIX
Based on our trend formula, NBIX is rated as a +85 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 141.67 | 143.39 | 141.18 | 142.65 | +1.75 |
| Prev. Close | Volume | Bid | Ask | Time |
| 142.73 | 424728 | 2025-09-17 15:57:14 |
| Year High | 126.98 | Year High Date | 2018-09-13 |
| Year Low | 74.12 | Year Low Date | 2018-01-17 |
| 52wk High | 154.61 | 52wk High Date | 2025-01-30 |
| 52wk Low | 84.23 | 52wk Low Date | 2025-04-09 |
| Year End Close | 7.48 | Average Volume | 739,861 |
| Shares Outstanding | 99,182 | Short Interest | 2,757,358 |
| % Institutional | 82.1 | Market Cap | 8,737M |
| Assets | 388,980,000M | Liabilities | 119,550,000M |
| P/E Ratio | 41.6864 | Beta | 0.3 |
| Volatility | 65.12 |